A code for clinical trials centralized monitoring, sharing open …
The COVID-19 pandemic promoted disruptions in the conduction of clinical trials, as on-site monitoring visits were adjourned. In this context, the transition to RBM by all actors involved in clinical trials has been encouraged. In order to ensure the highest quality of data within a COVID-19 clinical trial, a centralized monitoring tool alongside Case Report […]
A code for clinical trials centralized monitoring, sharing open … Read More »

